Sensory Nerve Coaptation in DIEP Flap Breast Reconstruction

Sponsor
Maastricht University Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT04093999
Collaborator
(none)
126
1
37
3.4

Study Details

Study Description

Brief Summary

Restoring the sensation of the breast becomes increasingly recognized as a critical part of autologous breast reconstruction. A prospective study was conducted of all patients who underwent either innervated or non-innervated deep inferior epigastric perforator (DIEP) flap breast reconstruction in Maastricht University Medical Center between August 2016 and August 2018 and who returned between for a follow-up visit between the start of the study and August 2019. Semmes-Weinstein monofilaments were used for sensory testing of the breast.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Sensory nerve coaptation

Study Design

Study Type:
Observational
Actual Enrollment :
126 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
Nerve Coaptation Improves the Sensory Recovery of the Breast in DIEP Flap Breast Reconstruction
Actual Study Start Date :
Aug 1, 2016
Actual Primary Completion Date :
Sep 1, 2019
Actual Study Completion Date :
Sep 1, 2019

Arms and Interventions

Arm Intervention/Treatment
Innervated DIEP flaps

Patients in this group underwent immediate or delayed, unilateral or bilateral DIEP flap breast reconstruction with additional sensory nerve coaptation.

Procedure: Sensory nerve coaptation
A recipient sensory nerve branch of the 11th-12th intercostal nerve was reattached to a donor nerve in the chest area. The anterior cutaneous branch of the second or third intercostal nerve was used as the donor nerve. Direct, end-to-end nerve coaptation was performed.
Other Names:
  • Neurotization
  • Reinnervation
  • Neurorrhaphy
  • Noninnervated DIEP flaps

    Patients in this group underwent immediate or delayed, unilateral or bilateral DIEP flap breast reconstruction without sensory nerve coaptation.

    Outcome Measures

    Primary Outcome Measures

    1. Mean monofilament value as a measure for the sensory recovery of the reconstructed breast [Through study completion up to 36 months postoperatively]

      The sensory recovery of the breast to touch was tested at different follow-up moments after the initial surgery. Semmes-Weinstein monofilaments were used for sensory testing. Nine areas of the breast, indicating native skin and flap skin, were tested. Mean monofilament values were calculated for each area and compared between groups.

    Secondary Outcome Measures

    1. Mean monofilament value as a measure for the sensory recovery of the reconstructed breast [Through study completion up to 36 months postoperatively]

      The sensory recovery of the donor site to touch was tested at different follow-up moments after the initial surgery. Semmes-Weinstein monofilaments were used for sensory testing. Four areas of the donor site were tested, two areas above and two areas below the scar. Mean monofilament values were calculated for the total donor site and compared between groups.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    Female
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Female patients 18 years or older

    • Unilateral or bilateral DIEP flap breast reconstruction

    • Returned for follow-up between August 2016 and August 2019

    • Informed consent

    Exclusion Criteria:
    • Total flap loss complication

    • Flaps that required a take-back

    • Follow-up less than six months postoperatively

    • Only one postoperative measurement at less than 12 months follow-up

    • Mixed reconstructions: an innervated breast reconstruction on one side and a noninnervated breast reconstruction on the other side

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Maastricht University Medical Center Maastricht Limburg Netherlands 6229 HX

    Sponsors and Collaborators

    • Maastricht University Medical Center

    Investigators

    • Principal Investigator: RenĂ© van der Hulst, MD, PhD, Maastricht University Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Rene van der Hulst, Head of the Plastic Surgery department, Maastricht University Medical Center
    ClinicalTrials.gov Identifier:
    NCT04093999
    Other Study ID Numbers:
    • METC 16 - 4 - 147
    First Posted:
    Sep 18, 2019
    Last Update Posted:
    Sep 23, 2019
    Last Verified:
    Sep 1, 2019
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Rene van der Hulst, Head of the Plastic Surgery department, Maastricht University Medical Center

    Study Results

    No Results Posted as of Sep 23, 2019